BioHybrid Solutions™ has been named one of the 40 “Best University Startups 2017” by the National Council of Entrepreneurial Tech Transfer. Antonina Simakova, Ph.D., BHS Director of Research and Development, will present at the University Startups Conference and Demo Day on April 18-19, 2017 in Washington, D.C.
The University Startups Conference and Demo Day brings together a diverse audience of over 300 people of university Startup Officers, university startups, entrepreneurs, Fortune 1000/Global 1000 corporations, VCs, angel investors, policy leaders, and federal government agencies. The event provides a venue to form and maintain robust transaction networks among the participants with the aim to align university IP and startups with investor and corporate needs.
More Company News
Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
Myris Therapeutics emerges from stealth to announce new name and strategic focus Proprietary polymer chemistry enables ultra-high drug to antibody ratios of 50 - 100 and new chemical space for precision targeted ADC payloads PITTSBURGH, Feb. 20,...
BioHybrid Solutions Holdings, Inc. Announces Expansion of its Drug Development Leadership
Pittsburgh, PA. June 02, 2023 Biohybrid Solutions Holdings, Inc. (BHS), is a biotechnology company using advanced polymer technologies to address outstanding challenges in the development of biologic drugs. BHS’ NanoArmor® technology balances...
BioHybrid Solutions Holdings, Inc. Appoints Mark Murcko as Board Member
Pittsburgh, PA. August 09, 2022 We are excited to announce the appointment of Mark Murcko, Ph.D., as our newest Board Member. Mark brings over three decades of industry experience, having been at the center of many transformational biotech efforts...